Association of interleukin-10 level with increased 30-day mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention

Circulation Journal

Volumn 71, Issue 7, 2007, Pages 1086-1091

  Yip, Hon Kan ^a   Youssef, Ali A ^c   Chang, Li Teh ^b   Yang, Cheng Hsu ^a   Sheu, Jiunn Jye ^a   Chua, Sarah ^a   Yeh, Kuo Ho ^a   Lee, Fan Yen ^a   Wu, Chiung Jen ^a   Hang, Chi Ling ^a,d  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b MEIHO UNIVERSITY   (Taiwan)

^c Suez Canal University Hospital   (Egypt)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

30 day mortality; Acute myocardial infarction; Interleukin 10

Indexed keywords

INTERLEUKIN 10;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; CARDIOGENIC SHOCK; CATHETERIZATION; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HUMAN; INCIDENCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PUNCTURE; RISK ASSESSMENT; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, BALLOON; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STENTS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME; TYROSINE;

EID: 34347206319     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1086     Document Type: Article

References (29)

1. Tedgui A, Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res 2001; 88: 877-887.
2. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
3. Yip HK, Wu CJ, Yang CH, Chang HW, Fang CY, Hung WC, et al. Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting: Role of inflammatory mediators in predicting late restenosis. Circ J 2005; 69: 890-895.
4. Grutz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol 2005; 77: 3-15.
5. Yip HK, Sun CK, Chang LT, Wu CJ. Strong correlation between serum levels of inflammatory mediators and their distribution in infarct-related coronary artery. Circ J 2006; 70: 838-845.
6. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
7. Maier W, Altwegg LA, Corti R, Gay S, Hersberger M, Maly FE, et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: Locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 2005; 111: 1355-1361.
8. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-2850.
9. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimo JJ. Atherothrombosis and high-risk plaque. Part I: Evolving concepts. J Am Coll Cardiol 2005; 46: 937-954.
10. Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, Francolini G, et al. Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study. Circulation 2005; 111: 863-870.
11. Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002; 105: 1412-1415.
12. Pinderski LJ, Michael P, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, et al. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res 2002; 90: 1064-1071.
13. Nishihira K, Imamura T, Yamashita A, Hatakeyama K, Shibata Y, Nagatomo Y, et al. Increased expression of interleukin-10 in unstable plaque obtained by directional coronary atherectomy. Eur Heart J 2006; 27: 1685-1689.
14. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003; 107: 2109-2114.
15. Yip HK, Wu CJ, Chang HW, Fang CY, Yang CH, Chen SM, et al. Effect of the PercuSurge GuardWire device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention in acute myocardial infarction. Am J Cardiol 2003; 92: 1331-1335.
16. Yip HK, Wu CJ, Chang HW, Hsieh YK, Fang CY, Chen SM, et al. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes. Chest 2003; 124: 962-968.
17. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001; 104: 746-749.
18. Shibata M, Endo S, Inada K, Kuriki S, Harada M, Iakino I, et al. Elevated levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res 1997; 17: 145-150.
19. Yip HK, Chang LT, Sun CK, Chen MC, Yang CH, Hung WC, et al Platelet activity is a biomarker of cardiac necrosis and predictive of untoward clinical outcomes in patients with acute myocardial infarction undergoing primary coronary stenting. Circ J 2006; 70: 31-36.
20. Yip HK, Wu CJ, Chang HW, Chen MC, Hang CL, Fang CY, et al. Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and elevation of prognostic determinants. Am J Cardiol 2001; 78: 1184-1188.
21. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: Predictors of slow-flow and no-reflow. Chest 2002; 122: 1322-1332.
22. Cannon CP, McCabe CH, Wilcox RG, Bentley JH, Braunwald E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris: OPUSTIMI 16 investigators. Am J Cardiol 2001; 87: 636-639.
23. Grzbowski M, Welch RD, Parsons L, Ndumele CE, Chen E, Zalenski R, et al. The association between white blood cell count and acute myocardial infarction in-hospital mortality: Findings from the national registry of myocardial infarction. Acad Emerg Med 2004; 11: 1049-1060.
24. Yang Z, Zingarelli B, Szabo C. Crucial rule of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 2000; 101: 1019-1026.
25. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, et al. Cardiac release of cytokines and inflammatory response in acute myocardial infarction. Circulation 1995; 92: 748-755.
26. Singh RB, Daniel D, Neki NS, Chandel JP, Rastogi S, Mori H, et al. Mechanisms of acute myocardial infarction study (MAMIS). Biomed Pharmacother 2004; 58: S111-S115.
27. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: A thrombolysis in myocardial infarction 10 substudy. Circulation 2000; 102: 2329-2334.
28. Wu CJ, Chang HW, Hung WC, Yang CH, Chen YH, Su CY, et al. N-terminal pro-brain natriuretic peptide is a biomarker of congestive heart failure and predictive of 30-day untoward clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J 2006; 70: 163-168.
29. The GUSTO angiographic investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. Circulation 1993; 329: 1615-1622.